PharmaShots | Incisive News in 3 Shots

Subscribe Now

Aligos

Aligos Discontinues ALG-020572 in the (ALG-020572-401) Study for the Treatment of Chronic Hepatitis B

Aligos Discontinues ALG-020572 in the (ALG-020572-401) Study for the Treatment of Chronic Hepatitis B

March 23, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us